Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chang Gung Biotechnology is a prominent Taiwanese healthcare and biotechnology company that focuses on the integration of Western science with Eastern wellness philosophies. Part of the Formosa Plastics Group, the company utilizes advanced nano-technology and large-scale bio-fermentation to develop a wide range of health supplements, functional foods, and wellness products. Its research and development efforts are closely linked with Chang Gung Memorial Hospital and Chang Gung University, focusing on the role of trace elements and microbial metabolites in human health. The company provides a variety of consumer products aimed at addressing chronic diseases and improving overall lifestyle through holistic restructuring. Chang Gung Biotechnology operates multiple manufacturing facilities and retail outlets, positioning itself as a leader in the Asian preventive medicine and nutraceutical markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chang Group.